Categories: News

Waters Corporation to Present at the Evercore 2024 HealthCONx Conference

MILFORD, Mass., Nov. 20, 2024 /PRNewswire/ — Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the 7th Annual Evercore HealthCONx Conference on Wednesday, December 4th, 2024 at 10:00AM Eastern Time.

A live webcast of the event will be available on the ‘Events & Presentations’ section of Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will be available for 90 days.

About Waters Corporation

Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 7,500 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

Caspar Tudor, Head of Investor Relations
investor_relations@waters.com

 

View original content:https://www.prnewswire.com/news-releases/waters-corporation-to-present-at-the-evercore-2024-healthconx-conference-302311918.html

SOURCE Waters Corporation

Staff

Recent Posts

Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET                   Orion and Invenra announce…

2 hours ago

Niger becomes the first country in sub-Saharan Africa to eliminate the transmission of onchocerciasis

DECATUR, Ga., Jan. 30, 2025 (GLOBE NEWSWIRE) -- On 30 January 2025, the World Health…

2 hours ago

IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025

WINTER SPRINGS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that…

2 hours ago

Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control

European patents expand coverage for both essential components of FemBloc for fallopian tube occlusion, resulting…

2 hours ago

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage…

2 hours ago